Cambrian Biopharma

United States
Troy, New Hampshire, United States, 11205

Company profile

Cambrian Biopharma company profile

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Business identity

Contact email
[email protected]
Phone number
(516) 962-3186
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
11205
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$160M
Last funding
Secondary Market / 2023-07-26
Last equity funding
Series C / $100M
Investors
21
Lead investors
3
Founders
3
Articles
15

Founders and investors

Founders

Christian AngermayerJames PeyerSebastian Brunemeier

Lead investors

Anthos CapitalFJ LabsSALT Fund

Investors

Alumni VenturesCatalio Capital ManagementFJ LabsFuture VenturesSprint Vc